Adverse events in cemiplimab therapy for locally advanced or metastatic cSCC: A global propensity-matched retrospective cohort study

Published: 30 May 2024| Version 1 | DOI: 10.17632/kn8swwnh2p.1
Contributors:
, Kyle Lauck,

Description

Supplemental Appendix for "Adverse events in cemiplimab therapy for locally advanced or metastatic cSCC: A global propensity-matched retrospective cohort study"

Files

Categories

Dermatology, Squamous Cell Carcinoma

Licence